Lastrapes R G, Parker J R, Kida M
Department of Radiological Sciences at the University of Oklahoma Health Sciences Center, USA.
J Okla State Med Assoc. 1995 Aug;88(8):333-6.
As the fourth leading cause of cancer death in the United States, pancreatic adenocarcinoma is both a diagnostic and a therapeutic challenge. Its incidence has risen in the past four decades so that pancreatic cancer ranks second to colon cancer as a leading cause of death from gastrointestinal malignancy. Despite technical and therapeutic advances, the prognosis remains dismal; the average survival time after diagnosis is characteristically only five to eight months. The current patient had a pancreatic adenocarcinoma that mimicked other disorders. Variability in clinical presentation and imaging studies warrants consideration of this entity in the differential diagnoses of many splenic and pancreatic lesions.